Advertisement
Home Tags Stents

Tag: Stents

Iliac Vein Stenting Appears Safe in Office-Based Lab Setting

0

7.36 percent of patients had minor complications, mainly insertion site hematomas; 0.41 percent had major complications

Cre8 EVO Stents Noninferior for PCI in Diabetes Patients With CAD

0

Cre8 EVO stents noninferior to Resolute Onyx stents for target-lesion failure composite outcome at one year

QFR-Guided Percutaneous Coronary Intervention Improves Outcomes

0

One-year clinical outcomes improved with quantitative flow ratio for lesion selection versus standard angiography guidance

FFR-Guided PCI Not Noninferior to CABG in Three-Vessel CAD

0

Findings not consistent with prespecified noninferiority of fractional flow reserve-guided percutaneous coronary intervention

Impact of Age Examined for Ticagrelor Monotherapy After PCI

0

Ticagrelor monotherapy reduces bleeding without increasing ischemic events among patients undergoing PCI

Ticagrelor, Prasugrel Compared in ACS Treated With PCI

0

Prespecified subgroup analysis of data from a randomized clinical trial suggest that a prasugrel-based strategy is preferable

Mortality Rate Not Up With Paclitaxel-Coated Devices in PAD

Deaths Not Up With Paclitaxel-Coated Devices in PAD

0

Interim analysis shows no increased rate of all-cause mortality with paclitaxel-coated versus uncoated devices

Polymer-based zotarolimus-eluting stents are noninferior to polymer-free drug-coated stents among patients at high bleeding risk undergoing percutaneous coronary intervention

Polymer-Based Stents Noninferior for Patients With High Bleeding Risk

0
Polymer-based zotarolimus-eluting stents noninferior for patients at high bleeding risk undergoing PCI
Many patients do not understand or remember the information given to them during the informed consent process for percutaneous coronary intervention

Many Patients Overestimate the Benefits of PCI

0
Study of the informed consent process reveals 60 percent of patients mistakenly believe PCI is curative
Paclitaxel drug-eluting devices used for endovascular revascularization of peripheral vessels do not appear to be associated with increased mortality over 11 years compared with uncoated devices

No Increased Mortality Seen With Paclitaxel Drug-Eluting Devices

0
In safety analysis, long-term mortality did not increase with use of paclitaxel-based devices